2026 EHA·精彩抢先看丨姜尔烈教授团队27项成果亮相欧洲血液学协会年会
发布时间:2026-05-06   

图片

2026年欧洲血液学协会年会(EHA 2026)将于6月11日至14日在瑞典斯德哥尔摩盛大召开。作为全球血液领域极具权威性与影响力的顶尖学术盛会,本届大会汇聚全球血液学领域权威专家、科研学者与临床医师,共享前沿进展,共探学科发展。本次EHA年会中,中国医学科学院血液病医院(中国医学科学院血液学研究所)姜尔烈教授团队携27项重磅研究成果精彩亮相,彰显中国科研团队在血液学领域的前沿探索能力与国际竞争力。


01

研究名称:REFINING PROGNOSTIC STRATIFICATION FOR SAML POST-ALLO-HSCT: VALIDATION OF ELN 2022 AND PREDOMINANT ROLE OF MDS-RELATED CYTOGENETICS.

第一作者:杨楠姜姗

通讯作者:庞爱明

报告类型:oral


















02

研究名称:PHASE II STUDY OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH AUTOLOGOUS CD19-CAR T CELL INFUSION IN ADULTS WITH HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CLINICAL OUTCOMES

第一作者:张荣莉

通讯作者:姜尔烈

报告类型:Poster Presentation


















03

研究名称:EFFICACY OF THE TRIPLET THERAPY WITH VENETOCLAX, AZACITIDINE AND GILTERITINIB FOR THE TREATMENT OF FLT3-ITD MUTATED R/R AML PATIENTS BRIDGING TO ALLOGENEIC STEM CELL TRANSPLANTATION

第一作者:梁晨

通讯作者:杨栋林姜尔烈

报告类型:Poster Presentation


















04

研究名称:CLINICAL IMPLICATIONS OF SUSTAINED HYPOBARIC HYPOXIA ON NEUTROPHIL ENGRAFTMENT AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

第一作者:曹易耕

通讯作者:曹易耕,崔森,Zhengping Zhuang,姜尔烈,耿惠

报告类型:Poster Presentation


















05

研究名称:UMBILICAL CORD BLOOD MONONUCLEARCELL INFUSION FOR SECONDARY POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION:A PHASE I DOSE-ESCALATION STUDY

第一作者:曹易耕

通讯作者:姜尔烈

报告类型:Poster Presentation


















06

研究名称:DOSE OPTIMIZATION OF ANTI-T LYMPHOCYTE GLOBULIN IN HAPLOIDENTICAL HSCT: A PROSPECTIVE RANDOMIZED NON-INFERIORITY TRIAL

第一作者:曹易耕

通讯作者:姜尔烈

报告类型:Poster Presentation


















07

研究名称:PRE-TRANSPLANT HIGH-DOSE METHOTREXATE AND INTENSIFIED INTRATHECAL PROPHYLAXIS DO NOT REDUCE CNS RELAPSE IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

第一作者:卢妮

通讯作者:姜尔烈

报告类型:Poster Presentation


















08

研究名称:ROMIPLOSTIM N01 FOR PROMOTING PLATELET ENGRAFTMENT AFTER ALLO-HSCT:INTERIM RESULTS OF A PHASE II EXPLORATORY TRIAL FROM NICHE COHORT

第一作者:姜姗

通讯作者:庞爱明

报告类型:Poster Presentation


















09

研究名称:INITIAL RESULTS OF POSTTRANSPLANTATION LOW-DOSE INOTUZUMAB OZOGAMICIN TO PREVENT RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA

第一作者:潘攀

通讯作者:庞爱明

报告类型:Poster Presentation


















10

研究名称:EARLY SC5B-9 AND EASIX AS PREDICTORS FOR RISK STRATIFICATION OF TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY IN ADULTS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

第一作者:郭雯雯 陈书连

通讯作者:曹文彬 姜尔烈

报告类型:Poster Presentation


















11

研究名称:DETERMINING PROGNOSTIC FACTORS IN PATIENTS WITH POSITIVE PRE-TRANSPLANT MRD BASED ON SPECIFIC ABNORMALITIES IN 2022 ELN

第一作者:李瑞鑫

通讯作者:姜尔烈

报告类型:Poster Presentation


















12

研究名称:COMPARISON OF TOTAL BODY IRRADIATION (TBI) AND NON-TBI CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH PRIMARY MYELOFIBROSIS 

第一作者:刘逸琳 王佳丽

通讯作者:杨栋林 姜尔烈

报告类型:Poster Presentation


















13

研究名称:SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NONHODGKIN LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

第一作者:石琳炜

通讯作者:庞爱明

报告类型:Poster Presentation


















14

研究名称:HIGH EFFICACY AND MANAGEABLE SAFETY OF MARIBAVIR AS FIRST LINE TREATMENT FOR CMV INFECTION IN ALLO-HSCT RECIPIENTS: A MULTICENTER, RETROSPECTIVE, CONTROLLED COHORT STUDY

第一作者:曹佳欣

通讯作者:庞爱明

报告类型:Poster Presentation


















15

研究名称:HIGH PRE-TRANSPLANT ANTI-A ANTIBODY TITER AND DELAYED LEUKOCYTE ENGRAFTMENT ARE INDEPENDENT RISK FACTORS FOR PURE RED CELL APLASIA AFTER HAPLOIDENTICAL HSCT IN AML PATIENTS

第一作者:冯丹

通讯作者:姜尔烈

报告类型:Poster Presentation


















16

研究名称:Recipient-originated macrophages regulate acute graft-versus-host-disease after allogeneic stem cell transplantation

第一作者:甄思思 申昱妍

通讯作者:冯四洲

报告类型:Poster Presentation


















17

研究名称:DEVELOPMENT AND APPLICATION EVALUATION OF AN OCCUPATIONAL STRESS REGULATION SYSTEM FOR NURSES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION UNITS BASED ON THE NJSS

第一作者:任晓旭

通讯作者:解文君

报告类型:publication only


















18

研究名称:LATENT CLASSES OF PSYCHOLOGICAL DISTRESS AND ITS ASSOCIATED FACTORS IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING THE PERI-TRANSPLANT PERIOD

第一作者:刘玉秋

通讯作者:解文君 姜尔烈

报告类型:publication only


















19

研究名称:PERI-TRANSPLANT NURSING CARE FOR A PATIENT WITH ACUTE MYELOID LEUKEMIA COMPLICATED WITH HEMOPHILIA A UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

第一作者:刘玉秋

通讯作者:解文君 姜尔烈

报告类型:publication only


















20

研究名称:ANALYSIS OF INFLUENCING FACTORS OF SLEEP QUALITY AND NURSING INTERVENTIONS IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION

第一作者:郭玉帅

通讯作者:解文君 姜尔烈

报告类型:publication only


















21

研究名称:EFFECT OF IMPROVED WEARING METHOD OF PORTABLE ELECTROCARDIOGRAM MONITOR IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING TREATMENT IN ISOLATION CHAMBER

第一作者:崔新荣

通讯作者:解文君 姜尔烈

报告类型:publication only


















22

研究名称:EFFECTS OF COMPREHENSIVE NURSING CARE MODEL ON COMPLICATIONS AND QUALITY OF LIFE IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION

第一作者:刘雨青

通讯作者:姜尔烈

报告类型:publication only


















23

研究名称:Comprehensive nursing management during the application of mesenchymal stem cells in the treatment of acute intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation in clinical trials

第一作者:徐明月

通讯作者:姜尔烈

报告类型:publication only


















24

研究名称:THE PROGNOSTIC IMPACT OF CEBPA MUTATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

第一作者:张贤靖

通讯作者:陈俊仁 姜尔烈

报告类型:publication only


















25

研究名称:A JOURNEY MAP STUDY OF THE PSYCHOLOGICAL EXPERIENCE OF PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION

第一作者:张秋会

通讯作者:解文君 姜尔烈

报告类型:publication only


















26

研究名称:LISAFTOCLAX AS A NOVEL BCL-2 INHIBITOR: EFFICACY AND SAFETY IN INDUCTION OR RE-INDUCTION COMBINED REGIMENS FOR HEMATOLOGIC MALIGNANCIES

第一作者:郝梦泽

通讯作者:姜尔烈

报告类型:publication only


















27

研究名称:LETERMOVIR FOR CYTOMEGALOVIRUS PREVENTION IN RELAPSED/REFRACTORY ACUTE LEUKEMIA AND LYMPHOMA RECEIVING SEQUENTIAL CD7 CAR-T CELL THERAPY BRIDGING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

第一作者:石琳炜

通讯作者:庞爱明

报告类型:publication only





















审核:姜尔烈教授团队

排版:Baa

执行:Baa










医脉通是专业的在线医生平台,“感知世界医学脉搏,助力中国临床决策”是平台的使命。医脉通旗下拥有Medseeker「临床指南」「用药参考」「医学文献王」「医知源」「e研通」「e脉播」等系列产品,全面满足医学工作者临床决策、获取新知及提升科研效率等方面的需求。

本平台旨在为医疗卫生专业人士传递更多医学信息。本平台发布的内容,不能以任何方式取代专业的医疗指导,也不应被视为诊疗建议。如该等信息被用于了解医学信息以外的目的,本平台不承担相关责任。本平台对发布的内容,并不代表同意其描述和观点。若涉及版权问题,烦请权利人与我们联系,我们将尽快处理。

(本网站所有内容,凡注明来源为"医脉通",版权均归医脉通所有,未经授权,任何媒体、网站或个人不得转载,否则将追究法律责任,授权转载时须注明"来源:医脉通"。本网注明来源为其他媒体的内容为转载,转载仅作观点分享,版权归原作者所有,如有侵犯版权,请及时联系我们。)
0
收藏
添加表情
全部评论
我要投稿
发表评论
扫码分享

微信扫码分享

回到顶部